OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy
Marina Bershteyn, Sonja Bröer, Mansi Parekh, et al.
Cell stem cell (2023) Vol. 30, Iss. 10, pp. 1331-1350.e11
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Agnete Kirkeby, Heather Main, Melissa Carpenter
Cell stem cell (2025) Vol. 32, Iss. 1, pp. 10-37
Closed Access | Times Cited: 12

AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation
Mohammad Qneibi, Sosana Bdir, Mohammad Bdair, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116151-116151
Closed Access | Times Cited: 16

Current state of the epilepsy drug and device pipeline
Samuel W. Terman, Laura Kirkpatrick, Lisa F. Akiyama, et al.
Epilepsia (2024) Vol. 65, Iss. 4, pp. 833-845
Open Access | Times Cited: 14

Stem cell therapeutics and gene therapy for neurologic disorders
Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00427-e00427
Open Access | Times Cited: 10

Cell therapy for neurological disorders
Soshana Svendsen, Clive N. Svendsen
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2756-2770
Closed Access | Times Cited: 9

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1528-1548.e17
Open Access | Times Cited: 8

Clinical translation of pluripotent stem cell-based therapies: successes and challenges
Josefine Rågård Christiansen, Agnete Kirkeby
Development (2024) Vol. 151, Iss. 7
Open Access | Times Cited: 7

Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi
Cell chemical biology (2024) Vol. 31, Iss. 8, pp. 1422-1446
Closed Access | Times Cited: 6

The Role of Parvalbumin Interneurons in Autism Spectrum Disorder
Yiwei Yao, Qian Li
Journal of Neuroscience Research (2024) Vol. 102, Iss. 10
Closed Access | Times Cited: 5

Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death
Abrar Hakami, Sebastiano Antonio Rizzo, Oliver J.M. Bartley, et al.
Neurotherapeutics (2025), pp. e00518-e00518
Closed Access

Therapeutic Advances in Drug-Resistant Epilepsy
Edwin Humberto Hodelin-Maynard, Diana Țînț, Judith González González, et al.
American Journal of Therapeutics (2025)
Closed Access

STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research
Silvestre Ruano-Rodríguez, Mar Navarro-Alonso, Benito Domínguez-Velasco, et al.
BioTech (2025) Vol. 14, Iss. 1, pp. 11-11
Open Access

GABAergic Interneuron Cell Therapy for Drug-Resistant Epilepsy
Junzi Chen, Zhongxia Li, Yi Wang, et al.
Neuroscience Bulletin (2024) Vol. 40, Iss. 5, pp. 680-682
Closed Access | Times Cited: 3

Advances in Human Cellular Mechanistic Understanding and Drug Discovery of Brain Organoids for Neurodegenerative Diseases
Lei Tong, Xiaoshuang Zhang, Gaoshuang Fu, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102517-102517
Closed Access | Times Cited: 3

Target inhibition of NAT10-mediated ac4C modification prevents seizure behavior in mice
Angela Zhang, Jingwen Yang, Meng Wang, et al.
Neuropharmacology (2025), pp. 110415-110415
Closed Access

Ayurveda therapy in the management of epilepsy
Shripathi Adiga, Ramya S Adiga, Kumar M. R. Bhat, et al.
Epilepsy & Behavior (2024) Vol. 159, pp. 110026-110026
Open Access | Times Cited: 3

Penidaleodiolides A and B, Cage-Like Polyketides with Neurotransmission-Regulating Activity from the Soil Fungus Penicillium daleae L3SO
Qingyuan Wang, He‐Ping Chen, Haobo Tao, et al.
Organic Letters (2024) Vol. 26, Iss. 36, pp. 7632-7637
Closed Access | Times Cited: 2

Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy
Cameron Beaudreault, Richard Wang, Carrie R. Muh, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 1027-1027
Open Access | Times Cited: 2

Optogenetic stimulation of a cortical biohybrid implant guides goal directed behavior
Jennifer Brown, Kara M. Zappitelli, Paul M. Dawson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Novel Mechanism, Drug Target and Therapy in Epilepsy
Cenglin Xu, Yi Wang, Zhong Chen
Neuroscience Bulletin (2024) Vol. 40, Iss. 5, pp. 561-563
Open Access | Times Cited: 1

Stem Cell Transplantation Represents a New Strategy for the Treatment of Epilepsy
Yuan Zhou, Yi Wang, Yang Lin
Neuroscience Bulletin (2024) Vol. 40, Iss. 5, pp. 673-676
Closed Access | Times Cited: 1

Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia
Xiaorong Zhang, Maoxiong Wu, Lin Cheng, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1

From cells to insights: the power of human pluripotent stem cell-derived cortical interneurons in psychiatric disorder modeling
Peiyan Ni, Lingyi Fan, Youhui Jiang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top